CRSPBought today, got a nice move. Published earlier this idea on X Getting an extension, I am trading this impulse up onlyLongby Alpha_MindUpdated 0
CRSP eyes on $64 for MAJOR support, Bounce Now or Break to DoomMapped are the key zones to watch. Currently at a MAJOR support zone. Expecting bounce, maybe the bottom. $ 62.34-64.03 is the immediate support. $ 42.00-44.01 is next major support below. $ 95.23-96.40 is the major resistance above. ======================================= . by EuroMotif6
CRSP breakout to Stage2, long The price breakout the stage1 of 58weeks by a very strong bullsih bar with a great volume it is in the stage2 Also it breakout the TL The MA and RS are positive an up I opened long at 64.53 SL 53 TP 100Longby MamounAliUpdated 3
Ascending Triangle breakout for CRSP....It appears as though CRSP is forming a micro ascending triangle that is likely to result in bullish momentum.... The Williams Alligator is widening to the upside and there was recently a bullish cross. This is inherently bullish, but could always change in an instant.... by satoshi1230
CRSP Trying to break past weekly supply zone! CRISPR Therapeutics is an amazing company that focuses on cloning and gene modification. It is the future of medicine. I like to buy CRISPR at the TrendCloud Crossovers on the 1 hour chart. We are pulling back into a weekly demand zone and looking for option chains around $49. If you want to lean more about investing in stocks for long-term wealth building then click the link in my profile for the best news and setups using TrendCloud. 05:47by thechrisjuliano6
CRSP - Symmetrical TriangleA symmetrical triangle on CRSP is one for the watch list. Upward break - long. Downward break - short.by brentmisenko1
CRISPR idea, more long termSo the odd event that one of their key employees as far as I could tell just decided to leave did spark the selloff recently. If it continues then dont bother with this stock. But if we see strength then maybe it will go up again. Especially if they continue with good earnings and success overall. I know, top tier analys. But just an idea. My goal is usually 100% up and thats it. But if they continue to provide good stuff then I dont see why this wouldnt go to new athLongby DagligHandel2
CRISPR Therapeutics ($CRSP) Impressive Stock Performance CRISPR Therapeutics (NASDAQ: NASDAQ:CRSP ) has climbed more than 60% this year and for good reason. The company and partner Vertex Pharmaceuticals delivered positive results from clinical trials of their blood disorders candidate, exacel, and investors bet on potential regulatory approvals to follow. All of this marks just the beginning of a great opportunity for long-term investors. Let's check out three reasons to buy CRISPR Therapeutics like there's no tomorrow. CRISPR Therapeutics recently said it's shifting its focus to its next-generation immuno-oncology candidates and dropping its initial ones -- including a candidate that was in late-stage development. Technical Analysis CRISPR Therapeutics has broken the ceiling of the falling trend. NASDAQ:CRSP is trading near the top of its 52-week range and above its 200-day simple moving average. The pivot points show that the current price is above the pivot point of 61.59 USD, indicating a bullish bias. Investors have been pushing the share price higher, and the stock still appears to have upward momentum. Longby DEXWireNews2
LONG: Perfect High Tight Flag forming on CRSPNASDAQ:CRSP High tight flags were first observed by legendary investor William O'Neil of IBD and CANSLIM fame. Check out the pattern on CRSP, showing an 86.12% gain in just 22 days. Notice the consolidation of 7.02% over the past week forming the high tight flag. Watch for a breakout on strong volume above the leading edge of the wedge for exponential gains. Predict that this will rise to above 120% in the coming weeks. Read more about the launch of an approved product driving these gains at Zacks . Longby HighTightFlags442
Pepe Special: $CRSPWOAH. NASDAQ:CRSP looking like a juicy setup. Type 3 return. On a gartley. On the weekly chart?? There's only two options. Either this thing dies and goes to goblin town or it pumps to the pearly pearlies. Currently at basement level prices and the risk to reward ratio is looking v nice. Green boi energy picking up too, check the volume over the past three weeks. TP 1-3 and SL shown above.Longby thomaszkry444
Keep it Crisp for 2025A little idea for CRSP trajectory over the next couple years. Looks like an Elliot wave cycle has just completed and the next impulse is going to start? If correct would see a 5x return and a retest of the all time high - Currently in a noticeable 'dip' but is it the bottom, where else could it rebound ? - Weekly RSI is in oversold but could go down more. Longby dsypher3
CRSP 2h 2023, 3d ChartKeeping an eye on CRSP as it heads into earnings. From the looks of it, this looks bottomed out. It is retesting its previous breakout, running into the 3d 100SMA and 21EMA. I think there are better opportunities out there, but if it does retest this price area successfully it does have a chance to run some.by cmerged0
CRSP: Big orrection after the next rally, but buy-the-dip.I believe that CRSP (Crispr Therapeutics) is about to undergo a severe correction soon. I scaled into this stock during the latter part of 2022 and the first part of 2023 and it is up nearly 70% and has generated about 40% of pure alpha for me relative to the SPX. So this has been an amazing performer for my total portfolio. I believe this run may be nearing a pullback and I expect the correction to be a very severe one. My suggestion is that this will form a triple-bottom/inverse head-and-shoulders pattern because this will be a subwave 2 correction and in theory, it should not overthrow the recent low by very much. I think the post-correction rally will be sizeable (it'll be a macro Wave 3) and the catalyst for this rally will be the steady trend of slowly improving earnings that they have demonstrated over the past year. (3 successive quarters of positive earnings calls - this has not been achieved since 2017) So, in essence, presuming nothing else changes, I believe we should buy the next dip for a significant Wave 3 rally that will exceed the all-time highs. In the meantime, expect lots of volatility, if you don't have the stomach for taking drawdowns or losses in the interim, you may want to sell the next rally so that you can buy back in. I will probably pursue this course of action myself purely as a matter of greed to preserve the alpha I have managed to capture. Happy biotech trading!Longby RogueEconomicsUpdated 1
Crispr I believe CRSP may have reached the local bottom for the time being, and will go up from here since it just completed a 50%-61% retracement.Longby tealeafbud0
CRSPR doing a classic Accumulation Phase #1 SchematicLooking for calls on CRSPR around the 45ish levels. Very bullish on this company and from what I can tell we may be able to even buy some call options now but odds are IMO we will re test the 45ish price levels and then BOOM expand to the upside.Longby kiashedgefund338
CRSP going to get someThis CSPR looks like it wants to get some. Nice IH&S breakout, with a target at 56.09. Trying to get some brownie points here so I can chat with you all! Let me now if you agree. Longby ftt432322
CRSP Looking to break out of triangle formation.CRSP Looking to break out of triangle formation. Tight stop is possible at 71.90. Longby The_Position_Trader2
CRSP shortBad ER, Bear div with rsi (yellow lines). Descending triangle (white lines). Easy short to $60 demand zone. Shortby saccoface3
CRISPR: Crunch time again CRISPR Therapeutics Short Term We look to Sell at 82.82 (stop at 88.85) Previous resistance located at 83.00. Short term oscillators have turned negative. Posted a Bearish Outside candle on the Daily chart. A lower correction is expected. Our profit targets will be 68.87 and 60.76 Resistance: 83.00 / 96.00 / 135.00 Support: 73.00 / 60.50 / 43.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses. Shortby Saxo2
$CRSP Long IdeaFollowing sector rotations as the economy "slows down" we have finance, healthcare and utilities up next to show strength in the market. With record CPI reported today, it is expected for Feds to raise 75bps next two meetings but the market may begin to price in a 100bps raise given the higher than estimated numbers. $CRSP is coming out of a wedge and has been showing relative strength along with other healthcare companies. Targets to the upside are 84, 87 and 91. OptionsSwing Analyst Daniel Betancourt Longby optionsswingUpdated 4
CRSP - DrifitngChart request for @HHSPN CRSP had gone oversold on the weekly and deeper than before so a big bounce may be on the cards. However it doesn't look good that its fallen below this long term demand trendline. I think what this show is that CRSP has hit its high for now and although it may have a good bounce it will likely drift back and forth across the trendline in correction until enough time has passed. This is one for the "miss list" imo. Not advice.by dRends35663
CRSP and WTZ2CRSP has likely been bottomed out after long downtrend. I used WTZ4 (Wave to Tunnel) for taking the first profit. Then, another chance occurs. I apply my favorite set up (WTZ2) with expectation of another trend. However, managing your own risks is still recommended. Good Luck!Longby surapats0
CRISPR breaking free? CRISPR Therapeutics Short Term We look to Buy a break of 73.10 (stop at 68.66) Further upside is expected and we look to set longs in early trade. The trend of higher lows is located at 60.50. Previous resistance, now becomes support at 73.00. A higher correction is expected. Our profit targets will be 82.99 and 94.00 Resistance: 83.00 / 96.00 / 135.00 Support: 73.00 / 60.50 / 43.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses. Longby Saxo5